This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Implicit parasitic Sepsis
AB1_SEPSIS_PARAS_IMPL
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditions
|
61648 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
176 |
4. Check minimum number of eventsNone |
176 |
5. Include endpointsNone |
176 |
6. Filter based on genotype QC (FinnGen only) |
171 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Implicit parasitic Sepsis
based on the number of shared cases.
Similar with more cases:
- Implicit parasitic Sepsis
- Implicit Sepsis
- Implicit Sepsis
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Condition for Implicit Sepsis (Organ dysfunction codes)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 171 | 96 | 75 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 54.32 | 50.69 | 58.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 176
- Matched controls
- 1760
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R55
ICD-10 Finland
Syncope and collapse
36.5
120.8
89
48
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.0
37.4
46
55
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
5.6
26.1
68
178
AA1AD
NOMESCO Finland
CT of head and brain
5.2
25.8
83
259
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
249.8
22.1
22
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
83.1
20.2
22
*
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
19.1
18
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
19.0
115
545
A07.1
ICD-10 Finland
Giardiasis [lambliasis]
187.0
16.8
17
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.4
16.5
53
158
P01AB01
ATC
metronidazole; oral, rectal
3.7
16.3
102
480
R06.0
ICD-10 Finland
Dyspnoea
3.7
16.2
78
309
R51.80
ICD-10 Finland
Headache
4.3
16.1
54
166
J01MA12
ATC
levofloxacin; systemic
4.0
15.6
58
192
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.7
15.5
76
303
TPH04
NOMESCO Finland
Cathetrisation of vein
3.9
15.5
61
210
R50.9
ICD-10 Finland
Fever, unspecified
4.4
15.5
47
134
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.6
14.1
39
103
C03CA01
ATC
furosemide; systemic
3.4
13.9
75
314
XF400
NOMESCO Finland
ECG with 12 standard connections
3.9
13.2
49
160
A07.9
ICD-10 Finland
Protozoal intestinal disease, unspecified
139.5
12.6
13
*
A41.9
ICD-10 Finland
Sepsis, unspecified
139.5
12.6
13
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.6
12.6
26
53
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
6.7
12.4
21
35
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.3
12.3
22
39
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.6
12.2
51
180
D64.9
ICD-10 Finland
Anaemia, unspecified
4.5
12.0
33
86
A10AB05
ATC
insulin aspart; parenteral
5.4
11.8
25
52
A06AC01
ATC
ispaghula (psylla seeds); oral
3.2
11.7
62
253
E0000UV, ,
ATC
3.0
11.6
93
479
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
11.5
61
249
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.2
11.5
34
94
J01FF01
ATC
clindamycin; systemic
3.1
11.4
66
283
H02AB06
ATC
prednisolone; systemic
3.0
11.4
102
557
N05BA01
ATC
diazepam; systemic, rectal
3.9
11.2
38
116
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
11.0
44
150
UJF32
NOMESCO Finland
Coloscopy
3.1
10.9
61
256
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
5.6
10.8
22
44
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
10.5
41
137
A06.0
ICD-10 Finland
Acute amoebic dysentery
+∞
10.5
10
*
N02AA05
ATC
oxycodone; systemic
3.4
10.5
47
172
JN4AD
NOMESCO Finland
Body CT examination
4.4
10.4
29
76
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
10.4
82
414
103
Kela drug reimbursment
Diabetes, insulin-treated
3.0
10.3
60
257
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
10.0
37
119
A04
ICPC
Weakness/tiredness general
3.3
9.5
42
152
A02BC05
ATC
esomeprazole; systemic
2.7
9.5
86
461
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.8
9.4
32
97
R42
ICD-10 Finland
Dizziness and giddiness
3.0
9.4
55
234
Z2221
NOMESCO Finland
Medical doctor
2.8
9.4
65
303
A28
ICPC
Limited function/disability NOS
3.3
9.4
42
153
N30.0
ICD-10 Finland
Acute cystitis
3.4
9.3
39
136
A02BC01
ATC
omeprazole; systemic
2.8
9.2
63
292
C03DA01
ATC
spironolactone; oral
3.7
9.2
32
99
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
3.1
9.1
46
180
WX002
NOMESCO Finland
Sedation and analgesia
3.0
9.0
49
200
N17
ICPC
Vertigo/dizziness
3.7
9.0
31
95
N05CF01
ATC
zopiclone; oral
2.7
9.0
74
376
UJF30
NOMESCO Finland
Ileoscopy through colon
3.8
9.0
30
90
R5140
NOMESCO Finland
Monitoring the use of the aid
3.6
8.9
33
106
J01MA06
ATC
norfloxacin; oral
3.4
8.9
36
123
XF404
NOMESCO Finland
Ambulatory ECG
4.2
8.7
25
67
R4110
NOMESCO Finland
Physiotherapy
2.7
8.7
66
321
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.3
8.7
38
136
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
8.6
8.6
18
23
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.5
8.5
22
54
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
+∞
8.4
8
*
B54
ICD-10 Finland
Unspecified malaria
+∞
8.4
8
*
1369X
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases
+∞
8.4
8
*
A10AE04
ATC
insulin glargine; parenteral
4.1
8.4
25
69
R53
ICD-10 Finland
Malaise and fatigue
2.7
8.3
60
283
A10AE05
ATC
insulin detemir; parenteral
5.2
8.3
18
38
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.7
8.2
28
85
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
8.2
48
203
R11
ICD-10 Finland
Nausea and vomiting
3.9
8.2
26
75
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.8
8.2
52
230
127
Kela drug reimbursment
Transplant complication
35.1
8.2
10
*
A10AC01
ATC
insulin (human); parenteral
4.3
8.2
22
56
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
8.1
78
422
SPAT1229
SPAT
Assessment of need for aid
4.5
8.1
21
52
A06AD11
ATC
lactulose; oral
3.3
8.0
34
119
R06AE07
ATC
cetirizine; oral
2.5
8.0
91
532
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
8.0
68
348
XF402
NOMESCO Finland
ECG with work load test
3.6
7.9
28
87
N06AX21
ATC
duloxetine; oral
3.4
7.9
32
109
WX892
NOMESCO Finland
Monitored bed care
4.4
7.9
21
53
J01MA02
ATC
ciprofloxacin; systemic
2.5
7.8
81
453
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.6
7.8
28
88
L04AA01
ATC
[U] ciclosporin
47.1
7.8
9
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.6
7.7
28
89
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.1
7.6
22
59
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
8.3
7.6
16
21
C07AB07
ATC
bisoprolol; oral
2.4
7.5
100
622
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
7.4
7.5
17
25
J96.1
ICD-10 Finland
Chronic respiratory failure
83.5
7.5
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.0
7.5
22
60
L28
ICPC
Limited function/disability (L)
2.9
7.4
40
161
N05AH04
ATC
quetiapine; oral
2.9
7.4
41
168
I50.9
ICD-10 Finland
Heart failure, unspecified
3.1
7.3
34
126
ZX120
NOMESCO Finland
Intravenous
3.5
7.2
27
87
SPAT1262
SPAT
Handing over of treatment supplies
2.9
7.2
38
151
N05CF02
ATC
zolpidem; oral
2.8
7.2
41
170
N02AX02
ATC
tramadol; systemic, rectal
2.4
7.2
86
508
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.7
7.2
46
203
Z3226
NOMESCO Finland
Physiotherapist
2.7
7.2
46
203
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
7.1
46
204
N03AX16
ATC
[U] pregabalin
2.6
7.0
52
246
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
7.0
32
117
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
7.0
50
233
N06AA09
ATC
amitriptyline; systemic
3.4
7.0
27
89
D06
ICPC
Abdominal pain localized other
3.8
7.0
22
63
A02BC03
ATC
lansoprazole; oral
2.4
6.9
62
321
SPAT1255
SPAT
Intravenous administration of medicine
4.6
6.9
17
40
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
6.9
37
148
H04AA01
ATC
glucagon; nasal, parenteral
9.9
6.9
13
14
E86
ICD-10 Finland
Volume depletion
11.6
6.9
12
11
I95.9
ICD-10 Finland
Hypotension, unspecified
41.7
6.8
8
*
WX402
NOMESCO Finland
General anaesthesia
2.7
6.8
44
195
E000001, ,
ATC
2.6
6.7
47
216
H04.10
ICD-10 Finland
Dry eye syndrome
3.0
6.7
33
126
B01AA03
ATC
warfarin; systemic
2.7
6.7
43
190
N03AX09
ATC
lamotrigine; oral
6.2
6.6
17
30
H02AB07
ATC
prednisone; oral
3.1
6.6
30
109
N05CD07
ATC
temazepam; oral
3.1
6.6
31
115
N05BA04
ATC
oxazepam; oral
2.4
6.6
58
297
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
6.5
26
87
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
6.5
23
71
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.6
6.5
18
35
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.4
6.5
25
82
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
15.0
6.5
10
7
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
72.4
6.5
7
*
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
72.4
6.5
7
*
S06.0
ICD-10 Finland
Concussion
3.1
6.4
29
105
H02AB04
ATC
methylprednisolone; systemic
2.9
6.4
34
135
W19
ICD-10 Finland
Unspecified fall
3.5
6.4
23
72
J02AC01
ATC
fluconazole; systemic
2.3
6.4
78
459
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
6.4
60
316
L04AA06
ATC
mycophenolic acid; systemic
18.9
6.3
9
5
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
6.7
6.3
15
24
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
6.3
6
*
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
6.3
6
*
J96.0
ICD-10 Finland
Acute respiratory failure
+∞
6.3
6
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.4
6.2
16
39
I50.0
ICD-10 Finland
Congestive heart failure
3.9
6.2
19
53
N03AX12
ATC
[U] gabapentin; oral
2.7
6.2
37
157
R02
ICPC
Shortness of breath/dyspnoea
3.1
6.1
28
102
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
6.1
41
184
XF600
NOMESCO Finland
Bloodpressure measurement
4.0
6.1
18
49
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
6.0
28
103
C07AB02
ATC
metoprolol; systemic
2.5
6.0
43
199
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
38
40
11.84
33.65
3.3
1.6
—
—
—
0
0
29
42
8.07
19.74
1.4
1.5
1.09
7.82
ug/l
0.47
23
35
38
76
6.10
19.10
2.2
1.5
—
—
—
0
0
56
177
4.17
16.12
3.1
1.7
—
—
—
0
0
42
108
4.79
15.76
6.6
3.0
1.39
1.90
mmol/l
0.40
37
86
54
169
4.17
15.72
3.2
1.9
2.21
2.37
g/l
1.04
49
152
51
158
4.14
14.99
3.3
1.9
17.92
23.37
%
1.89
44
140
111
573
3.54
14.87
7.4
3.6
33.97
36.24
g/l
3.48
106
537
98
484
3.31
13.83
4.9
2.7
—
—
—
0
0
56
200
3.64
13.27
3.2
1.9
10.20
13.93
umol/l
2.39
50
180
41
118
4.23
13.19
2.8
1.6
—
—
—
0
0
41
118
4.23
13.19
2.9
1.7
—
—
—
0
0
83
381
3.23
13.09
4.8
2.6
0.25
0.28
e6/l
0.12
59
279
117
658
3.32
12.96
14.5
5.1
1.20
1.22
mmol/l
1.26
107
552
132
802
3.58
12.77
9.8
3.6
6.88
6.61
mmol/l
0.66
126
736
116
665
3.18
12.13
11.6
5.4
27.39
27.96
%
0.24
107
631
41
126
3.94
12.00
13.3
5.1
1.21
1.09
mmol/l
0.06
35
103
68
291
3.18
11.88
2.5
1.8
1.36
1.03
mg/l
0.39
57
226
58
228
3.30
11.65
3.8
3.2
615.96
182.55
ng/l
0.74
46
175
113
657
3.01
11.18
11.0
5.2
57.58
57.15
%
0.16
105
622
96
542
2.70
9.55
2.7
1.9
103.20
91.13
pmol/l
1.57
58
262
53
220
3.02
9.49
4.2
2.4
3.31
0.94
e6/l
0.43
27
128
125
808
2.89
9.47
14.5
9.1
4.29
4.01
e9/l
0.53
111
718
32
100
3.69
9.02
4.2
2.6
64.64
66.94
g/l
1.11
26
95
41
151
3.24
8.96
15.0
5.0
104.51
103.77
mmol/l
0.41
41
151
29
85
3.89
8.95
4.1
2.2
1.69
1.83
mmol/l
0.06
22
65
67
325
2.71
8.90
2.0
1.5
18.27
21.57
nmol/l
1.17
60
260
49
202
2.98
8.82
4.4
2.5
4.40
1.86
e6/l
0.45
23
111
68
335
2.68
8.73
3.0
1.9
2.72
2.94
mg/l
0.41
62
279
149
1086
3.42
8.60
13.3
6.5
74.55
78.86
u/l
0.89
143
1000
67
330
2.66
8.58
4.7
2.7
347.57
4828.93
umol/l
1.23
56
282
23
59
4.33
8.46
2.9
1.9
1.59
1.46
g/l
0.23
23
47
75
395
2.57
8.33
4.3
3.0
1369.31
1367.12
ng/l
0.00
64
326
23
61
4.19
8.10
2.3
1.7
—
—
—
0
0
55
252
2.72
8.06
1.9
1.6
882.33
1199.10
nmol/l
2.12
41
182
16
19
9.14
8.01
2.3
1.7
—
—
—
0
0
79
433
2.50
7.99
3.9
2.1
53.69
68.58
u/l
0.73
70
390
15
16
10.13
7.96
2.2
1.8
—
—
—
0
0
99
605
2.45
7.84
4.5
2.6
115.32
106.31
ug/l
0.19
93
549
16
20
8.68
7.79
2.4
1.7
—
—
—
0
0
13
11
12.64
7.71
1.8
1.5
—
—
—
0
0
36
136
3.07
7.47
3.2
2.7
6.27
7.50
umol/l
0.45
30
115
12
10
12.77
7.19
2.3
1.6
—
—
—
0
0
26
82
3.55
7.18
5.0
3.1
100.89
82.52
ng/l
0.51
19
73
91
554
2.33
7.04
3.1
2.1
74.61
76.24
nmol/l
0.25
84
476
88
531
2.31
6.92
5.5
3.7
50.31
46.14
ng/l
0.08
70
366
17
40
4.60
6.92
1.4
1.2
—
—
—
0
0
15
21
7.70
6.87
2.0
1.8
—
—
—
0
0
25
80
3.48
6.75
1.9
1.2
—
—
—
0
0
18
46
4.24
6.62
1.6
1.2
—
—
—
0
0
10
7
15.04
6.48
2.4
1.3
—
—
—
0
0
19
52
3.98
6.39
1.2
2.6
—
—
—
0
0
10
8
13.15
6.16
2.4
1.4
—
—
—
0
0
10
8
13.15
6.16
1.8
1.3
—
—
—
0
0
79
474
2.21
6.11
4.4
3.0
2.31
2.35
mmol/l
1.94
72
418
60
323
2.30
6.01
1.5
1.2
1.16
1.31
u/ml
0.06
11
84
17
45
4.07
5.97
1.6
1.2
—
—
—
0
0
102
686
2.16
5.81
6.2
3.5
0.00
0.00
estimate
-0.00
18
135
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
28
5.75
5.68
3.9
2.0
0.37
0.34
u/ml
—
8
14
101
682
2.13
5.63
8.8
4.5
0.00
0.00
estimate
-0.00
20
143
100
677
2.10
5.49
6.3
3.4
0.05
0.00
estimate
0.48
21
153
30
124
2.71
5.23
2.7
2.2
9.09
6.79
ug/l
0.34
25
106
11
15
7.74
5.23
1.9
1.5
—
—
—
0
0
93
622
2.05
5.18
20.8
12.3
1.31
1.26
inr
0.16
26
197
10
13
8.08
4.92
2.5
2.0
—
—
—
0
0
34
156
2.46
4.79
1.8
1.6
1.67
1.51
%
0.43
28
131
135
1054
2.21
4.75
6.9
3.8
15.15
11.09
mm/h
1.70
130
953
10
14
7.50
4.72
2.5
1.9
—
—
—
0
0
10
14
7.50
4.72
2.5
1.9
—
—
—
0
0
10
14
7.50
4.72
2.5
1.9
—
—
—
0
0
18
59
3.28
4.67
2.3
2.2
0.94
1.20
%
0.63
18
59
7
5
14.49
4.61
1.6
2.0
—
—
—
0
0
7
5
14.49
4.61
1.6
2.0
—
—
—
0
0
55
314
2.09
4.61
4.2
2.1
—
—
—
0
0
8
8
10.40
4.56
1.5
1.6
—
—
—
0
0
10
15
7.00
4.53
2.5
1.9
—
—
—
0
0
10
15
7.00
4.53
2.5
1.9
—
—
—
0
0
11
19
6.10
4.52
1.9
1.4
—
—
—
0
0
20
72
3.01
4.46
20.9
5.7
0.69
0.70
%
0.06
20
72
15
45
3.55
4.43
2.9
1.7
—
—
—
0
0
14
33
4.52
4.43
2.7
4.8
42.19
27.83
mg/l
0.79
14
28
14
33
4.52
4.43
2.7
4.8
62.41
224.51
mg/l
0.43
14
28
11
20
5.79
4.36
1.4
1.2
—
—
—
0
0
20
73
2.96
4.35
20.6
5.7
1.42
1.47
%
0.06
20
73
14
34
4.38
4.32
3.5
2.2
—
—
—
0
0
8
10
8.31
4.10
1.6
1.6
—
—
—
0
0
64
404
1.92
3.96
5.3
3.3
15.06
7.76
mg/mmol
0.61
47
236
8
11
7.56
3.90
3.1
1.7
—
—
—
0
0
8
11
7.56
3.90
3.1
1.7
—
—
—
0
0
19
72
2.84
3.88
1.3
1.4
—
—
—
0
0
6
5
12.35
3.79
1.7
2.0
—
—
—
0
0
6
5
12.35
3.79
1.7
2.0
—
—
—
0
0
13
34
4.04
3.78
4.3
2.2
23.73
25.09
mmol/l
0.43
13
34
42
232
2.06
3.77
1.2
1.2
31.83
29.04
iu/ml
—
6
73
115
883
1.87
3.77
3.7
3.0
—
—
—
0
0
163
1424
2.96
3.75
34.7
11.8
26.07
22.06
mg/l
0.81
140
1100
8
13
6.39
3.54
2.1
1.5
—
—
—
0
0
8
13
6.39
3.54
1.6
1.5
—
—
—
0
0
6
6
10.29
3.52
3.3
1.2
—
—
—
0
0
6
6
10.29
3.52
3.3
1.2
—
—
—
0
0
6
6
10.29
3.52
1.8
1.3
—
—
—
0
0
6
6
10.29
3.52
1.8
2.0
75.00
94.00
%
—
6
6
88
633
1.78
3.48
4.6
2.3
—
—
—
0
0
13
42
3.26
3.45
3.6
2.2
8.36
8.45
kpa
0.08
13
42
10
23
4.54
3.36
2.2
1.4
—
—
—
0
0
27
131
2.25
3.34
2.3
1.9
356.86
373.08
nmol/l
0.18
21
119
14
49
3.02
3.27
2.6
1.9
—
—
—
0
0
130
1060
1.87
3.27
4.7
3.9
14.86
14.78
pmol/l
0.12
119
947
151
1299
2.14
3.18
6.2
4.6
1.98
2.86
mu/l
0.45
145
1153
12
35
3.60
3.17
1.8
1.2
—
—
—
0
0
45
270
1.90
3.17
2.1
1.6
436.15
462.34
pmol/l
0.30
40
219
7
12
6.02
3.05
3.0
1.4
701.00
653.00
e6/l
—
7
12
5
5
10.24
2.99
1.4
1.8
—
—
—
0
0
5
5
10.24
2.99
1.0
1.4
—
—
—
0
0
5
5
10.24
2.99
1.4
1.8
—
—
—
0
0
11
32
3.60
2.96
3.5
3.1
206.82
200.34
%
0.07
11
32
7
13
5.56
2.90
3.6
1.8
—
—
—
0
0
5
6
8.53
2.76
1.4
1.7
—
—
—
0
0
5
6
8.53
2.76
3.8
5.2
818.20
1113.00
u/ml
—
5
6
6
10
6.17
2.72
4.0
2.1
—
—
—
0
0
6
10
6.17
2.72
1.2
1.1
—
—
—
0
0
18
80
2.39
2.71
1.0
1.0
—
—
—
0
0
44
275
1.80
2.70
3.5
2.7
2.40
2.44
mmol/l
1.55
38
247
36
214
1.86
2.58
1.2
1.3
3.12
7.31
u/ml
—
10
92
5
7
7.31
2.56
1.0
1.1
—
—
—
0
0
5
7
7.31
2.56
1.6
2.0
15.00
11.00
u/l
—
5
7
5
7
7.31
2.56
1.0
1.1
—
—
—
0
0
161
1449
2.30
2.55
39.7
13.4
138.97
139.72
mmol/l
3.14
161
1404
7
16
4.51
2.50
1.0
1.1
—
—
—
0
0
161
1453
2.27
2.46
40.0
13.5
3.95
3.97
mmol/l
0.47
161
1407
6
12
5.13
2.42
1.2
1.2
—
—
—
0
0
8
22
3.76
2.39
1.9
1.5
—
—
—
0
0
8
22
3.76
2.39
1.3
1.5
—
—
—
0
0
8
22
3.76
2.39
1.3
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
8
6.39
2.38
1.0
1.3
—
—
—
0
0
163
1495
2.22
2.10
36.8
14.0
88.64
75.96
umol/l
1.83
163
1495
5
10
5.11
2.08
1.6
1.7
—
—
—
0
0
5
10
5.11
2.08
1.6
1.7
—
—
—
0
0
5
10
5.11
2.08
1.6
1.7
—
—
—
0
0
6
15
4.10
2.05
1.0
1.1
—
—
—
0
0
140
1231
1.67
2.01
35.5
14.5
14.84
14.88
%
0.03
140
1210
150
1344
1.79
2.00
29.6
11.9
77.77
81.75
ml/min/173m2
1.02
126
1087
7
21
3.43
1.98
1.1
1.6
—
—
—
0
0
7
22
3.27
1.90
1.3
1.1
—
—
—
0
0
6
17
3.61
1.85
1.0
1.1
—
—
—
0
0
9
35
2.65
1.83
8.4
1.8
—
—
—
0
0
53
384
1.54
1.80
6.9
3.7
0.00
0.00
estimate
-0.00
20
137
5
13
3.92
1.72
1.4
1.2
—
—
—
0
0
5
132
0.36
1.71
1.0
1.7
—
—
—
0
0
148
1338
1.67
1.69
4.7
3.9
1.35
1.27
mmol/l
0.63
137
1208
8
32
2.57
1.62
1.1
1.3
—
—
—
0
0
38
262
1.57
1.59
1.6
1.6
—
—
—
0
0
8
33
2.49
1.56
1.3
1.4
—
—
—
0
0
13
65
2.08
1.53
4.5
1.8
—
—
—
0
0
24
149
1.71
1.51
3.4
2.1
—
—
—
0
0
15
80
1.96
1.50
4.7
1.8
—
—
—
0
0
10
45
2.30
1.49
2.1
1.8
—
—
—
0
0
67
529
1.43
1.46
7.4
3.6
—
—
—
0
0
5
17
3.00
1.37
1.0
1.2
—
—
—
0
0
5
17
3.00
1.37
1.2
1.1
—
—
—
0
0
5
17
3.00
1.37
1.0
1.2
—
—
—
0
0
5
17
3.00
1.37
1.4
1.6
—
—
—
0
0
0
40
0.00
1.34
0.0
1.4
—
84.52
—
0
40
153
1418
1.60
1.30
5.9
4.8
2.53
2.75
mmol/l
2.41
145
1293
5
18
2.83
1.29
3.0
5.1
—
—
—
0
0
5
18
2.83
1.29
1.0
1.2
—
—
—
0
0
5
18
2.83
1.29
1.0
1.2
—
—
—
0
0
5
18
2.83
1.29
1.0
1.1
—
—
—
0
0
5
18
2.83
1.29
1.0
1.2
—
—
—
0
0
143
1308
1.50
1.27
8.1
5.4
41.13
39.57
mmol/mol
1.03
138
1209
8
36
2.28
1.26
1.1
1.1
—
—
—
0
0
150
1387
1.55
1.25
5.3
4.4
4.29
4.64
mmol/l
3.63
139
1276
23
149
1.63
1.25
6.9
3.0
—
—
—
0
0
5
19
2.68
1.22
1.4
1.1
—
—
—
0
0
5
19
2.68
1.22
1.8
2.3
110.20
105.42
mmol/l
—
5
19
149
1378
1.53
1.22
5.2
4.3
1.38
1.47
mmol/l
1.47
136
1254
49
378
1.41
1.19
1.8
1.6
1.58
1.37
mmol/l
0.61
41
316
5
20
2.54
1.16
2.6
1.2
0.32
0.35
nmol/l
—
5
13
7
30
2.39
1.13
1.3
1.8
—
—
—
0
0
5
21
2.42
1.10
1.2
1.1
—
—
—
0
0
147
1379
1.40
0.88
5.6
4.4
6.24
5.89
mmol/l
1.59
134
1243
8
44
1.86
0.87
1.5
2.3
—
—
—
0
0
23
166
1.44
0.81
3.7
2.2
—
—
—
0
0
164
1585
1.51
0.64
49.2
18.0
39.26
40.22
%
1.73
157
1500
5
30
1.69
0.62
2.0
1.6
—
—
—
0
0
164
1589
1.47
0.58
47.9
18.1
129.48
135.62
g/l
5.14
164
1559
14
104
1.38
0.44
2.5
3.0
55.38
66.07
ml/min/173m2
—
8
41
22
176
1.29
0.44
16.5
7.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
18
207
0.85
0.20
1.6
1.4
—
—
—
0
0
29
269
1.09
0.12
2.3
2.9
0.55
0.71
ug/l
0.73
24
171
39
369
1.07
0.11
3.4
4.3
21.99
21.87
%
0.01
13
170
5
47
1.07
0.09
1.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
46.81
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
100.59
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AB1_SEPSIS_PARAS_IMPL – Implicit parasitic Sepsis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).